Die Onkologie pp 1521-1552 | Cite as

Weichteilsarkome im Erwachsenenalter

  • H. Sauer
  • C. Wendtner
  • M. Schlemmer
  • R. D. Issels
  • W. Hiddemann

Zusammenfassung

Weichteilsarkome (WS; Synonym: Weichgewebssarkome, maligne Weichgewebstumoren, maligne mesenchymale Tumoren, „Soft-Tissue Sarcoma“: STS) werden entsprechend den Regeln der WHO wie folgt definiert (Enzinger u. Weiss 1988): maligne Tumoren des nichtepithelialen, extraskelettalen Gewebes mit Ausnahme des hämatopoetischen, lymphatischen oder retikuloendothelialen Systems, der Glia und des Stützgewebes spezifischer Organe und der viszeralen Gewebe, eingeschlossen die Tumoren der peripheren Nerven und des autonomen Nervensystems.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abe H,Terui S,Terauchi T et al. (1997) Comparison of TC-99 M pertechnetate with TL-201 and GA-67 scintigraphy of malignant soft-tissue tumors. Clin Nucl Med 22: 38–41Google Scholar
  2. Alekhteyar KM, Leung DH, Brennan MF, Harrison LB (1996) The effect of combined external beam radiotherapy and brachytherapy an local control and wound complications in patients with high-grade softtissue sarcomas of the extremity with positive microscopic margin. Int J Radiat Oncol Biol Phys 36: 321–324PubMedGoogle Scholar
  3. Antonescu CR, Argani P, Erlandson RA, Healey JH, Landanyi M, Huvos AG (1998) Skeletal and extraskeletal myxoid chondrosarcoma:a comparative clinicopathologic, ultrastructural, and molecular study. Cancer 83: 1504–1521PubMedGoogle Scholar
  4. Antoniuk P,Tjandra JJ, Lavery IC (1993) Diffuse intra-abdominal fibromatosis in association with bilateral ovarian fibromatosis and oedema.Austr New Zea J Surg 63: 315–318Google Scholar
  5. Argani P, Perez-Ordonez B,Xiao H,Caruana SM, Huvos AG, Ladanyi M (1998) Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol 22: 391–398PubMedGoogle Scholar
  6. Ayala AG, Ro JY, Fanning CV, Flores JP,Yasko AW (1995) Core needle biopsy and Eine needle aspiration in the diagnosis of bone ants soft-tissue lesions. Hematol Oncol Clin N Amer 9: 633–651Google Scholar
  7. Balcerzak SP, Benedetti J, Weiss GR, Natale RB (1995) A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas–A Southwest Oncology Group Study. Cancer 76: 2248–2252PubMedGoogle Scholar
  8. Beech DJ, Pollock RE (1995) Surgical management of primary soft tissue sarcoma. Hematol Oncol Clin N Amer 9: 707–718Google Scholar
  9. Benjamin RS, Pollock RE, Zagars GK (1995) Soft tissue sarcomas of the extremities–continuing challenges for a multidisciplinary team. Cancer Invest 13: 137–138PubMedGoogle Scholar
  10. Bennicelli JL, Barr FG (1999) Genetics and the biologic basis of sarcomas. Curr Op Oncol 11: 267–274Google Scholar
  11. Blair SC, Zalupski MM, Baker LH (1994) Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas. Am J Clin Oncol Cancer Clin Trials 17: 480–484Google Scholar
  12. Blanke CD, Eisenberg BL, Heinrich MC (2001) Gastrointestinal stromal tumors. Cu rr Treat Options Oncol 2: 485–491Google Scholar
  13. Bloechle C, Peiper M, Schwarz R, Schroeder S, Zornig C (1995) Post-irradiation soft tissue sarcoma. Eur J Cancer 31A: 31–34Google Scholar
  14. Blomgvist C,Wiklund T, Pajunen M,Virolainen M, Elomaa I (1995) Oral trofosfamide–an active drug in the treatment of soft-tissue sarcoma. Cancer Chemother Pharmacol 36: 263–265Google Scholar
  15. Bobin JY, Rivoire M, Delay E, Elarini A, Mignotte H,Wagner P,Zlatoff P (1994) Radiation induced sarcomas following treatment for breast cancer–presentation of a series of 14 cases treated with an aggressive surgical approach.) Surg Oncol 57: 171–177Google Scholar
  16. Bowne WB, Antonescu CR, Leung DH et al. (2000) Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.Cancer 88: 2711–2720Google Scholar
  17. Brady MS, Perino G,Tallini G, Russo P, Woodruff JM (1996) Malignant mesenchymoma. Cancer 77: 467–473PubMedGoogle Scholar
  18. Bramwell VJ, Rouesse W, Steward A et al. (1994) Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma–reduced local recurrence but no improvement in survival–A study of the European Organization for Research and Treatment of Cancer SoftTissue and Bone Sarcoma Group.J Clin Oncol 12: 1137–1149Google Scholar
  19. Bramwell VHC, Eisenhauer EA, Blackstein M, Boos G, Knowling M, Jolivet J, Bogues W (1995) Phase 11 study of topotecan (NSC 609 699) in patients with recurrent of metastatic soft tissue sarcoma. Annals of Oncology 6: 847–849PubMedGoogle Scholar
  20. Bramwell VHC (1995) The role of chemotherapy in osteogenic sarcoma (review). Crit Rev Oncol Hematol 20: 61–85PubMedGoogle Scholar
  21. Brennan ME (1996) Management of soft tissue sarcoma. Brit J Surg 83: 577–579PubMedGoogle Scholar
  22. Brennan MF (1996)The surgeon as a leader in cancer care - lessons leamed from the study of soft tissue sarcoma.) Am Coll Surg 182:520–529Google Scholar
  23. Brizel DM, Scully SP, Harrelson JM et al. (1996) Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 56: 5347–5350PubMedGoogle Scholar
  24. Budach V, Dinges S (1995) Strahlentherapie der Weichteilsarkome im Erwachsenenalter. Aktueller Stand und Perspektiven. Onkologe 1: 110–118Google Scholar
  25. Budach W,BudachV,Socha B,Stuschke M,Streffer C,Sack H (1994) DNA content as a predictor of clinical outcome in soft tissue sarcoma patients. Eur J Cancer 30A: 1815–1821Google Scholar
  26. Bui BN, Chevallier B, Chevreau C et al. (1995) Efficacy of lenograstim an hematologic tolerance to maid chemotherapy in patients with advanced soft tissue sarcoma and consequences an treatment dose-intensity. J Clin Oncol 13: 2629–2636PubMedGoogle Scholar
  27. Cakir S, Dincbas FO,Uzel O, Koca SS,Okkan S (1995) Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma. Radiother Onco137: 10–16Google Scholar
  28. Calaminus G, Jürgens H,Schwambom D,Janäen G,Göbel U (1989) Experience with the combination carboplatinNP 16 in recurrent childhood tumors. Int Soc Pediat Oncol STOP XXI Meeting, Sept.18–22, AbstractGoogle Scholar
  29. Calonje E, Fletcher CDM (1995) Immunohistochemixtry and DNA flow cytometry in soft tissue sarcomas. Hematol Oncol Clin N Am 9: 657675Google Scholar
  30. Carnevale A, Lieberman E,Cardenas R (1997) Li-Fraumeni syndrome in pediatric patients with soft tissue sarcoma or osteosarcoma. Arch Med Res 28: 383–386PubMedGoogle Scholar
  31. Casali P, Pastorino U, Azzarelli A, Bertulli R, Zucchinelli P, Devizzi L, Santoro A (1993) Perspectives an anthracyclines plus ifosfamide in advanced soft tissue sarcomas. Cancer Chemother Pharmacol 31 [Supp121 5228–232Google Scholar
  32. Casper ES (2000) Gastrointestinal stromal tumors. Curr Treat Options On-col 1: 267–273Google Scholar
  33. Cemy T, Schmoll HJ, Hartlapp JH, Schlag PM (1997) Weichteilsarkome, S 1504–1536.In:Schmoll HJ, Höffken K, Possinger K (Hrsg) Kompendium Internistische Onkologie, Teil 2, 2. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  34. Charisius J, Meden H, Schauer A, Kuhn W (1996) Cystosarcoma phylloides malignum: Klinische Befunde, morphologische Besonderheiten and therapeutische Möglichkeiten.Tumor Diagn Ther 17: 63–66Google Scholar
  35. Cheng EY, Dusenbery KE, Winters MR,Thompson RC (1996) Soft tissue sarcomas- preoperative versus postoperative radiotherapy.J Surg Oncol 61: 90–99Google Scholar
  36. Chetty R, Kalan MR (1992) Malignant granular cell tumor of the breast. J Surg Onco149: 135–137Google Scholar
  37. Choong PFM, Gustafson P, Rydholm A (1995) Size and timing of local recurrence predicts metastasis in soft tissue sarcoma–growth rate index retrospectively analyzed in 134 patients. Acta Orthop Scand 66: 147–152PubMedGoogle Scholar
  38. Choong PFM, Pritchard DJ, Rock MG, Sim FH, Frassica FJ (1995) Survival after pulmonary metastasectomy in soft tissue sarcoma–prognostic factors in 214 patients. Acta Orthop Scand 66: 561–568PubMedGoogle Scholar
  39. Coard K, Branday JM, Lagrenade L (1994) Dermatofibrosarcoma protuberans–a 10-year clinicopathological review of an uncommon tumour. West Indian Med 143: 130–133Google Scholar
  40. Coindre JM,Terrier P,Bui NB et al. (1996) Prognostic factors in adult patients with locally controlled soft tissue sarcoma–a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14: 869–877Google Scholar
  41. Coindre JM,Trojani M, Contesso G, David M, Rouesse J et al. (1986) Reproducibility ofa histopathologic grading system for adult soft tissue sarcoma. Cancer 58: 306–309Google Scholar
  42. Colon G, Quint DJ, Blaivas M, McGillicuddy J (1995) Cardiac sarcoma metastatic to the brain. Am J Neuroradiol 16: 1739–1741PubMedGoogle Scholar
  43. Conlon KC, Casper ES, Brennan MF (1995) Primary gastrointestinal sarco-mas–analysis of prognostic variables. Ann Surg Oncol 2: 26–31PubMedGoogle Scholar
  44. Connelly EF, Budd GT (1996) Ifosfamide in the treatment of soft tissue sarcomas. Semin Onco123: 16–21Google Scholar
  45. Conrad EU, Bradford L,Chansky HA (1996) Pediatric soft-tissue sarcomas. Orthop Clin N Am 27: 655Google Scholar
  46. CooperTM,Collins D, Sheehan M,OconnorTP (1996) Soft tissue sarcoma of the extremity. Ann R Coll Surg Engl 78: 453–456Google Scholar
  47. Costa MJ, Campman SC, Davis RL, Howell LP (1996) Fine needle aspiration cytology of sarcoma–retrospective review of diagnostic utility and specificity. Diagn Cytopathol 15: 23–32PubMedGoogle Scholar
  48. Couture J, Mitri A,Lagace R et al. (2000) A germline mutation at the extreme 3’end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 57: 205–212PubMedGoogle Scholar
  49. Culine S,Lhomme C, Kattan J, Michel G, Duvillard P,DrozJP (1997) Cisplatinbased chemotherapy in the management of germ cell tumors of the ovary–The Institut Gustave Roussy Experience. Gynecol Onco164. 160–165Google Scholar
  50. De Chiara A,T’Ang A,TricheTJ (1993) Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas.J Natl Cancer Inst 85: 152–157Google Scholar
  51. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hunderd gastrointestinal stromal tumors: recurrence patterns ans prognostic factors for survival. Ann Surg 231: 51–58PubMedGoogle Scholar
  52. DeMatteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33: 466–477PubMedGoogle Scholar
  53. Demetri GD (1996) High dose ifosfamide in the treatment of sarcomas of tissues and bone.Semin Oncol 23: 22–26Google Scholar
  54. Demetri GD, Elias AD (1995) Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas–implications for decision making in the clinic (review). Hematol Oncol Clin N Am 9: 765–785Google Scholar
  55. Demetri GD, von Mehren M, Blanke CD et al. (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347: 472–480PubMedGoogle Scholar
  56. Dinges S, Budach V, Budach, Feldman Hi, Stuschke M, Sack H (1994) Local recurrences of soft tissue sarcomas in adults–a retrospective analysis of prognostic factors in 102 cases after surgery and radiation therapy. Eur J Cancer 30A: 1636–1642Google Scholar
  57. Dirix LY,van Oosterom AT (1994) Diagnosis and treatment of soft tissue sarcomas in adults.Curr Opin Oncol 6: 372–383Google Scholar
  58. Donner LR,Trompler RA, White RR (1996) Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) or soft tissue into sarcoma after several recurrences. Hum Pathol 27: 1095–1098Google Scholar
  59. Dubois JB, Debrigode C, Hay M, Gely S, Rouanet P, Saintaubert B, Pujol H (1995) Intra-operative radiotherapy in soft tissue sarcomas.Radiother Oncol 34: 160–163Google Scholar
  60. Dundore PA, Cheville JC, Nascimento AG, Farrow GM, Bostwick DG (1995) Carcinosarcoma of the prostate–report of 21 cases. Cancer 76: 1035–1042PubMedGoogle Scholar
  61. Edmonson JH, Buckner JC, Long Hi, Loprinzi CL, Schaid DJ (1989) Phase-II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas.J Nat Cancer Inst 81: 863–866Google Scholar
  62. Edmonson JH, Ebbert LP, Nascimento AG, Jung SH, Mcgaw H, Gerstner JB (1996) Phase II study of docetaxel in advanced soft tissue sarcomas. Am J Clin Oncol Cancer Clin Trials 19: 574–576Google Scholar
  63. Eggermont AMM, Koops HS, Klausner JM et al.1996 a) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas–The Cumulative Multicenter European Experience. Ann Surg 224: 756–765Google Scholar
  64. Eggermont AMM, Koops HS, Lienard D, Kroon BBR,Vangeel AN, Hoekstra HJ, Lejeune FJ (1996 b) Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas–a multicenter trial. J Clin Oncol 14: 2653–2665Google Scholar
  65. Eilber F, Eckardt J, Rosen G, Forscher C, Selch M, Fu YS (1995) Preoperative therapy for soft tissue sarcoma. Hematol Oncol Clin N Amer 9: 817–823Google Scholar
  66. El-Rifai W, Sarlomo-Rikala M,Andersson LC, Miettinen M, Knuutila 5 (1998) DNA copy number changes in gastrointestinal stromal tumors–a distinct genetic entity. Ann Chir Gynaecol 87: 287–290Google Scholar
  67. Enzinger FM, Weiss SW (1988) Soft tissue tumors.2nd edn. Mosby, St. Louis Washington TorontoGoogle Scholar
  68. Erkisi M, Erkurt E, Ozbarlas S, Burgut R, Doran F, Seyrek E (1996) The use of recombinant human granulocyte colony-stimulating factor in combination with single or fractionated doses of ifosfamide and doxorubicin in patients with advanced soft tissue sarcoma. J Chemother 8: 224–228PubMedGoogle Scholar
  69. Evans HL (1995) Classification and grading of soft tissue sarcomas -a comment. Hematol Oncol Clin N Am 9: 653–656Google Scholar
  70. Evans MJ,Langlois NEI,Kitchener HC, Miller ID (1995)1s there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed mullerian tumor) of the uterus? Int J Gynecol Cancer 3: 310–313Google Scholar
  71. Falk M, Issels R (2001) Hyperthermia in oncology. Int J Hyperthermia 17: 1–18PubMedGoogle Scholar
  72. Fein DA, Corn BW, Lanciano RM, Herbert SH, Hoffman JP, Coia LR (1995) Management of retroperitoneal sarcomas–does dose escalation impact an locoregional control? Int J Radiat Oncol Biol Phys 31: 129–134PubMedGoogle Scholar
  73. Fein DA, Lee WR, Lanciano RM et al. 1995 ) Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation–do total dose,overall treatment time,and the surgery-radiotherapy interval impact an local control. Int J Radiat Oncol Biol Phys 32: 969–976PubMedGoogle Scholar
  74. Fetscher S,Kiani A,Kanz L, Brugger W, Lange W, Mertelsmann R (1996) Neo-adjuvant high-dose chemotherapy with autologous peripheral blood stem cell transplantation for inoperable relapse of nuchal liposarcoma resistant to standard-dose chemotherapy. Ann Onco17: 871Google Scholar
  75. Fish FS (1996) Soft tissue sarcomas in dermatology. Dermatol Surg 22: 268–273PubMedGoogle Scholar
  76. Fisher C (1996) Soft tissue sarcomas-diagnosis,classification and prognostic factors. Brit J Plastic Surg 49: 27–33Google Scholar
  77. Fizazi K, Feuillard J, Lecesne A,Terrier P, Raphael M, Pouillart P,TurszT (1996) Soft tissue sarcomas in HIV-infected adult patients. Eur J Cancer 32A: 1812–1814Google Scholar
  78. Fletcher CD, Berman JJ,Corless C (2002) Diagnosis of gastrointestinal stromal tumors:a consensus approach. Int J Surg Pathol 10: 81–89Google Scholar
  79. Frassica FJ,Thompson RC (1996) Evaluation, diagnosis, and classification of benign soft tissue tumors.) Bone Joint Surg Am 78A: 126–140Google Scholar
  80. Fraumeni JF (1996) An interdisciplinary approach to populations at high risk of Cancer. Cancer 78: 548–552PubMedGoogle Scholar
  81. Frost DB (1995) Pulmonary metastasectomy for soft tissue sarcomas–is it justified.) Surg Oncol 59: 110–115Google Scholar
  82. Fuchs R, Schadeck-Gressel C, Makoski HB (1995) Ergebnisse einer adjuvanten postoperativen kombinierten Chemo-/Radiotherapie bei hochmalignen Weichteilsarkomen.Tumor Diagn Ther 16: 26–31Google Scholar
  83. Gadducci A, Sartori E, Landoni F et al. (1996) Endometrial stromal sarcoma - analysis of treatment failures and survival. Gynecol Onco163: 247253Google Scholar
  84. Garcia JR, Kim EE, Wong FCL, Korkmaz M, Wong WH, Yang Di, Podoloff DA (1996) Comparison of fluorine-18-DFG PET and technetium-99MMIBI SPECT in evaluation of musculoskeletal sarcomas. J Nucl Med 37: 1476–1479PubMedGoogle Scholar
  85. Gartner HV,Seidl C,Luckenbach C,Schumm G,Seifried E, Ritter H, Bultmann B (1996) Genetic analysis of a sarcoma accidentally transplanted from a patient to a surgeon. N Engl J Med 335: 1494–1496Google Scholar
  86. Gebhardt MC (1996) Molecular biology of sarcomas. Orthopedic Clinics of North America 27:421 ffGoogle Scholar
  87. Gerald WL,Ladanyi M,de Alava E,Cuatrecasas M, Kushner BH,LaQuaglia MP, Rosai J (1998) Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;g12): desmoplastic small round-cell tumor and its variants.) Clin Oncol 16: 3028–3036Google Scholar
  88. Giarola M,Wells D, Mondini P et al.1998) Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 78: 582–587Google Scholar
  89. Goldstein DJ, Oz MC, Rose EA, Fisher P, Michler RE (1995) Experience with heart transplantation for cardiac tumors.) Heart Lung Transplant 14: 382–386Google Scholar
  90. Golouh R, Bracko M, Novak J (1996) Predictive value of proliferation-related markers, P53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas. Mod Pathol 9: 919–924PubMedGoogle Scholar
  91. Goodlad JR, Fletcher CDM, Smith MA (1996) Surgical resection of primary soft-tissue sarcoma–incidence of residual tumour in 95 patients needing re-excision after local resection. J Bone Joint Surg Brit 78B: 658–661PubMedGoogle Scholar
  92. Gullu I, Yalcin S, Tekuzman G (1996) High-dose ifosfamide by infusion with mesna in advanced refractory sarcomas. Cancer Invest 14: 239242Google Scholar
  93. Gustafson P, Femo M, Akerman M, Baldetorp B, Willen H, Killander D, Rydholm A (1997) Flow cytometric s-phase fraction in soft-tissue sarcoma -prognostic importance analysed in 160 patients. Bri J Cancer 75: 94–100Google Scholar
  94. Hachitanda Y,Toyoshima S, Akazawa K,Tsuneyoshi M (1998) Nmyc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features. Mod Pathol 11: 1222–1227Google Scholar
  95. Hafner GH, Rao U, Karakousis CP (1995) Liver metastases from soft tissue sarcomas.J Surg Oncol 58: 12–16Google Scholar
  96. Ham SJ, Hoekstra HJ,VandergraafWTA,KampsWA,Molenaar WM,Koops HS (19969 The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.) Clin On-col 14:490–496Google Scholar
  97. Han P, Drachtman RA, Amenta P, Ettinger U (1996) Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide. J Pediatr Hematol Oncol 18: 314–317PubMedGoogle Scholar
  98. Hartmann 0 (1995) New strategies for the application of high-dose chemotherapy with haematopoietic support in paediatric solid tumours. Ann Onco16: 13–16Google Scholar
  99. Hartmann JT,Thiel I, Schmoll Hi, Einsele H, Kanz L, Bokemeyer C (1996) Malignant fibrous histiocytoma of bone–review of thirteen cases.Oncol Rep 3: 813–817Google Scholar
  100. Heeten den GJ, Koops HS, Kamps WA, Oosterhuis JW, Sleijfer DT, Oldhoff J (1985)Treatment of malignant fibrous histiocytoma of bone:a plea for primary chemotherapy. Cancer 56: 37–40Google Scholar
  101. Heinrich MC, Blanke CD, Druker Bi, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KITPositive malignancies.) Clin Onco120:1692–1703Google Scholar
  102. Hermanek P,Scheibe O,Spiessl B,Wagner G (Hrsg) (1992)TNMKlassifikation malignerTumoren,4.Aufl. Springer, Berlin Heidelberg NewYorkTokyoGoogle Scholar
  103. Heslin MJ, Woodruff J, Brennan MF (1996) Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma–implications for management.) Clin Oncol 14: 473–478Google Scholar
  104. Hicks LG, Balcerzak SP,Zalupski M (1996) GM-CSF did not allow doxorubicin dose escalation in the maid regimen–a phase 1 trial–A Southwest Oncology Group Study. Cancer Invest 14: 507–512PubMedGoogle Scholar
  105. Hieken TJ, DasguptaTK (1996) Mutant p53 expression–a marker of diminished survival in well differentiated soft tissue sarcoma.Clin Cancer Res 2: 1391–1395Google Scholar
  106. Hirakawa N, Naka T,Yamamoto I, FukudaT,Tsuneyoshi M (1996) Overexpression of bc1–2 protein in synovial sarcoma–a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol 27: 1060–1065Google Scholar
  107. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279: 577–580PubMedGoogle Scholar
  108. Hoekstra HJ, Sindelar WF, Szabo BG, Kinsella TJ (1995) Hemipelvectomy and intraoperative radiotherapy for bone and soft tissue sarcomas of the pelvic girdle. Radiother Onco137: 160–163Google Scholar
  109. Höffken K, Bamberg M, Schlag P (1995) Weichteilsarkome ( Themenheft ). Onkologe 1: 84–138Google Scholar
  110. Hohenberger P (1995) ChirurgischeTherapie von Weichgewebssarkomen. Onkologe 1: 101–109Google Scholar
  111. Hollowood K, Fletcher CDM (1995) Soft tissue sarcomas that mimic benign lesions. Semin Diagn Pathol 12: 87–97PubMedGoogle Scholar
  112. Howmangiles R, Uren RF, Shaw PJ (1995) Thallium 201 scintigraphy in pediatric soft-tissue tumors.J Nucl Med 36: 1372–1376Google Scholar
  113. Huang KT, Chen CA, Tseng GC, Chen TM, Cheng WF, Hsieh CY (1996) Endometrial stromal sarcoma of twenty cases. Acta Obstet Gynecol Scand 75: 551–555PubMedGoogle Scholar
  114. Hung),Anderson R (1997) p53:functions, mutations and sarcomas.Acta Orthop Scand 273:-68–73Google Scholar
  115. Huuhtanen RL, Blomgvist CP, Wiklund TA, Virolainen MJ, Elomaa Al Pan Y, Tribukait B (1996) S-phase fraction of 155 soft tissue sarcomas -correlation with clinical outcome. Cancer 77: 1815–1822PubMedGoogle Scholar
  116. Huvos AG (1995) The Importance of the open surgical biopsy in the diagnosis and treatment of bone and soft tissue tumors. Hematol Oncol Clin N Am 9: 541–544Google Scholar
  117. Iezzoni JC, Mills SE (1993) Sarcomatoid carcinomas (carcinosarcomas) of the gastrointestinal tract - a review. Semin Diagn Pathol 10: 176187Google Scholar
  118. Issels R ( 1995 a) Empfehlungen zur Diagnostik,Therapie und Nachsorge - Knochentumoren/Weichteilsarkome. Schriftenreihe des Tumorzentrum München, 3. Aufl. Selbstverlag,Tumorzentrum MünchenGoogle Scholar
  119. Issels RD, Prenninger SW, Nagele A et al. (1990) Ifosfamide plus etoposide combined with regional hyperthennia in patients with locally advanced sarcomas - a phase-11 study.) Clin Onco18:1818–1829Google Scholar
  120. Issels RD, Bosse D, Abdelrahman S et al. (1993a) Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma–a pilot study. Cancer Chemother Pharmacol 31: 233–237Google Scholar
  121. Issels RD, Bosse D, Starck M, Abdelrahman S, Jauch KW, Schildberg FW, Wilmanns W (1993b) Soft-tissue tumors–hyperthermia–indications and results. Chirurg 64: 461–467PubMedGoogle Scholar
  122. Issels RD (1995 b) Soft tissue sarcomas - What is currently being done? Eur J Surg Oncol 21 [Suppl] A 469–477Google Scholar
  123. Issels RD (1995 c) Kombinationstherapie bei Weichteilsarkomen im Erwachsenenalter. Bayer Internist 15:19–29Google Scholar
  124. Issels RD, Mittermüller H, Wilmanns W (1991) Regionale Tiefenhyperthermie in der Onkologie. Eine Bestandsaufnahme. Dtsch Ärztebl 88: B-145-B-153Google Scholar
  125. Issels RD, Abdel-Rahman S, Wendtner CM, Flak MH, Kurze V, Sauer H, Aydemir U, Hiddemann W (2001) Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent highrisk soft tissue sarcomas (HR-STS) of adults: Longterm results of a phase II study. Eur J Cancer 37: 1599–1608Google Scholar
  126. Jacobs JE, Birnbaum BA, Siegelman ES (1966) Heterotopic ossification of midline abdominal incisions - CT and MR imaging findings. Am J Röntgenol166: 579584Google Scholar
  127. Jaques DP,Coit DG,Casper ES, Brennan MF (1995) Hepatic metastases from soft tissue sarcoma. Ann Surg 221: 392–397Google Scholar
  128. Jenkins MP,Alvaranga JC,ThomasJM (1996)The management of retroperitoneal soft tissue sarcomas. Eur J Cancer 32A:622–626Google Scholar
  129. Johnston MR, Minchen RF, Dawson CA (1995) Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 110: 368–373PubMedGoogle Scholar
  130. Jones DN, McCowage GB,Sostman HD et al. (1996) Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.) Nucl Med 37: 1438–1444Google Scholar
  131. Karakousis CP, Proimakis,C,Walsh DL (1995) Primary soft tissue sarcoma of the extremities in adults. Brit J Surg 82: 1208–1212Google Scholar
  132. KarakousisCP,VelezAF,Gerstenbluth R,Driscoll DL (1996) Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol 3: 150–158Google Scholar
  133. Karakousis CP (1995 a) Die chirurgische Therapie der Weichteilsarkome. I. Allgemeine Prinzipien und Resektionen am Stamm. Chirurg 66:905913Google Scholar
  134. Karakousis CP ( 1995 b) Die chirurgische Therapie der Weichteilsarkome.II. Resektionsbehandlung der Extremitätensarkome. Chirurg 66: 1006 1015Google Scholar
  135. Karlsson P, Holmberg E,Johansson KA,Kindblom LG,Carstensen J,Wallgren A (1996) Soft tissue sarcoma after treatment for breast cancer. Radiother Onco 138: 25–31Google Scholar
  136. Katenkamp D, Kosmehl H (1995) Epidemiologie, Ätiologie und Pathologie der Weichgewebssarkome. Onkologe 1: 86–92Google Scholar
  137. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338: 153–160PubMedGoogle Scholar
  138. Kawai A, Fukuma H, Beppu Y, Yokoyama R, Tsuchiya R, Kondo H, Inoue H (1995) Pulmonary resection for metastatic soft tissue sarcomas. Clin Orthop Rel Res 310: 188–193Google Scholar
  139. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T (1998) Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58: 5009–5013PubMedGoogle Scholar
  140. Kilkenny JW, Bland KI, Copeland EM (1996) Retroperitoneal sarcoma -The University of Florida Experience.J Am Coll Surg 182: 329–339Google Scholar
  141. King AA, Debaum MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1.Am J Med Genet 93: 388–392Google Scholar
  142. Kirn DH, Kramer A (1996) Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma.J Natl Cancer Inst 88: 764–765Google Scholar
  143. Kole AC, Nieweg OE,Vanginkel RI et al. (1997) Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using (F18) fluorodeoxyglucose. Ann Surg Oncol 4: 57–63PubMedGoogle Scholar
  144. Koscielniak E, Jurgens H, Winkler K et al. 1992 ) Treatment of soft tissue sarcoma in childhood and adolescence–a report of the German cooperative soft tissue sarcoma study. Cancer 70: 2557–2567PubMedGoogle Scholar
  145. Kostakoglu L, Panicek DM, Divgi CR, Botet J, Healy J, Larson SM, Abdeldayem HM (1995) Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.EurJ Nucl Med 22: 1232–1237Google Scholar
  146. Kransdorf MJ (1995) Malignant soft-tissue tumors in a large referral population–distribution of diagnoses by age, sex, and location. Am J Roentgenol 164: 129–134Google Scholar
  147. Kruzelock RP, Hansen MF (1995) Molecular genetics and cytogenetics of sarcomas. Hematol Oncol Clin N Am 9: 513–540Google Scholar
  148. Kudelka AP,TermrungruanglertW,Vadhanraj S et al.1996) Remission of advanced uterine leiomyosarcoma with pulmonary metastases with carboplatin and paclitaxel.Anticancer Drugs 7:885–889Google Scholar
  149. Kung FH, Pratt CB,Vega RA et al. 1993 ) Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood–a pediatric oncology group phase-11 study. Cancer 71: 1898–1903PubMedGoogle Scholar
  150. Kuttesch JF, Wexler LH, Marcus RB et al. 1996 ) Second malignancies after Ewing’s sarcoma–Radiation dose-dependency of secondary sarcomas. J Clin Oncol 14: 2818–2825PubMedGoogle Scholar
  151. Lange W, Mertelsmann R (1997) Blutstammzelltransplantation -Gegen-wärtiger Stand and Perspektiven. Dtsch Med Wschr 122: 129–131PubMedGoogle Scholar
  152. Lawrence W (1994) Soft tissue sarcomas in adults and children–a comparison. CA Cancer) Clin 44: 197–199Google Scholar
  153. Lecesne A,Antoine E, Spielmann M et al. (1995) High-dose ifosfamide–circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.J Clin Oncol 13: 1600–1608Google Scholar
  154. Ledoussal V, Coindre 1M, Leroux A et al. (1996) Prognostic factors for patients with localized primary malignant fibrous histiocytoma–a multicenter study of 216 patients with multivariate analysis. Cancer 77: 1823–1830Google Scholar
  155. Leopold KA, Dewhirst M, Samulski T et al. (1992) Relationships among tumor temperature,treatment time, and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas. Int J Radiat Oncol Biol Phys 22: 989–998PubMedGoogle Scholar
  156. Lewis JJ, Leung D, Heslin M,WoodruffJM, Brennan MF (1997) Association of local recurrence with subsequent survival in extremity soft tissue sarcoma.J Clin Oncol 15: 546–652Google Scholar
  157. Li C, Bapat B, Alman BA (1998) Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 153: 709–714PubMedGoogle Scholar
  158. Li CW, Kuesel AC, Padavicshaller KA et al. (1996) Metabolic characterization of human soft tissue sarcomas in vivo and in vitro using protondecoupled phosphorism magnetic resonance spectroscopy. Cancer Res 56: 2964–2972PubMedGoogle Scholar
  159. Lynch HT, Fitzgibbons R, Chong S, Cavalieri J, Lynch J, Wallace F, Patel S (1994) Use of doxorubicin and dacarbacine for the management of unresectable intra-abdominal desmoid tumors in gardners syndrome. Dis Colon Rectum 37: 260–267PubMedGoogle Scholar
  160. Massengill AD, Seeger LL, Eckardt 1J (1995) The role of plain radiography, computed tomography,and magnetic resonance imaging in sarcoma evaluation. Hematol Oncol Clin N Am 9: 571–604Google Scholar
  161. Mau H, Ewerbeck V, Reichardt P, Bernd L, Sabo D (1995) Malignant fibrous histiocytoma of bone and soft tissue–two different tumour entities–a retrospective study of 45 cases. Onkologie 18: 573–579Google Scholar
  162. Mautner VF, Lindenau M, Kaufmann D (1995) Klinik und Genetik der Neurofibromatose. Neurofibromatose ist mehr als Morbus Recklinghausen. Dtsch Ärzteb192-. B-1292-B-1296Google Scholar
  163. Mcgrath PC, Sloan DA,Kenady DE (1995) Adjuvant therapy of softtissue sarcomas.Clin Plastic Surg 22: 21–29Google Scholar
  164. McGregor GI, Knowling MA, Este FA (1994) Sarcoma and cystosarcoma phyllodes tumors of the breast–a retrospective review of 58 cases. Am J Surgery 167: 477–480Google Scholar
  165. Mertens WC, Bramwell VHC (1995) Adjuvant chemotherapy for soft tissue sarcomas. Hematol Oncol Clin N Am 9: 801–815Google Scholar
  166. Michelotti A, Romanini A, Giannessi P, Bengala C, Conte P (1996) Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas. Am J Clin Oncol Cancer Clin Trials 19: 78–81Google Scholar
  167. Miser JS, Kinsella TJ,TricheTJ,Tsokos M,Jarosinski P et al. (1987) Ifosfamide with mesna uroprotection and etoposide–an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.J Clin Oncol 5: 1191–1198Google Scholar
  168. Moore MP, Kinne DW (1996) Breast sarcoma. Surg Clin N Am 76:383 Morgan RW, Elcock M (1995) Artificial implants and soft tissue sarcomas. J Clin Epidemiol 48: 545–549Google Scholar
  169. Mukherjee A, Malcolm A, Delahunt M, Neal DE (1995) Pelvic fibromatosis (desmoid)–treatment with steroids and tamoxifen. Brit J Urology 75: 559–560Google Scholar
  170. Mundt AJ,Awan A,Sibley GS et al.1995) Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities -clinical and radiobiological results.IntJ Radiat Oncol Biol Phys 32:977–985Google Scholar
  171. Munk PL, Poon PY, Chhem RK,Janzen DL (1994) Imaging of soft tissue sarcomas.Can Assoc Radiol J 45: 438–446Google Scholar
  172. NazeerT, Barada JH, Fisher HAG, Ross JS (1991) Prostatic carcinosarcoma–case report and review of literature.) Urol 146. 1370–1373Google Scholar
  173. Newman PL, Fletcher CDM (1991) Malignant mesenchymoma -clinico-pathologic analysis of a series with evidence of low-grade behaviour. Am J Surg Pathol 15: 607–614PubMedGoogle Scholar
  174. Newton WA, Gehan EA, Webber BL et al. (1995) Classification of rhabdomyosarcomas and related sarcomas–pathologic aspects and proposal for a new classification–Intergroup Rhabdomyosarcoma Study. Cancer 76: 1073–1085PubMedGoogle Scholar
  175. Nieweg 0E, Pruim J, Vanginkel RJ et al. 1996 ) Fluorine-l8fluorodeoxyglu- cose PET imaging of soft-tissue sarcoma.J Nucl Med 37: 257–261Google Scholar
  176. Nishida J, Sim FH, Wenger DE, Unni KK (1997) Malignant fibrous histiocytoma of bone–a clinicopathologic study of 81 patients. Cancer 79: 482–493PubMedGoogle Scholar
  177. NisolleJF,Delaunois L,TrigauxJP (1996) Myositis ossificans of the chest wall. Eur Respir J 9: 178–179Google Scholar
  178. Noguera R (1996) Cytogenetics and tissue culture of small round cell tu- mors of bone and soff tissue.Semin Diagn Pathol 13: 171–183Google Scholar
  179. Oerter R, Kaiser D (1995) Pulmonale Metastasen von Weichteilsarkomen–was leistet die Metastasenchirurgie? Pro und Contra aus der Sicht des Chirurgen. Onkologe 1: 136–139Google Scholar
  180. Olieman AFT,Vanginkel RJ,Hoekstra HJ,Mooyaart EL, Molenaar WM,Koops HS (1997) Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Ann Surg Oncol 4: 64–69Google Scholar
  181. Panicek DM, Gatsonis C, Rosenthal D1 (1997) CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms–report of The Radiology Diagnostic Oncology Group. Radiol 202: 237–246Google Scholar
  182. Peiper M, Zurakowski D, Zornig C (1995) Lokalrezidive von Weichteilsarkomen an Extremitäten und Rumpf. Langenbecks Arch Surg 380: 333–339Google Scholar
  183. Pendlebury SC, Bilous M, Langlands AO (1995) Sarcomas following radiation therapy for breast cancer–a report of three cases and a review of the literature. Int J Radiat Oncol Biol Phys 15: 405–410Google Scholar
  184. Penn 1(1993) Incidence and treatment of neoplasia after transplantation.Google Scholar
  185. J Heart Lung Transplant 12 [Suppl S]: 328–336Google Scholar
  186. Pisters PWT, Harrison LB, Leung DHY,Woodruff JM, Casper ES, Brennan MF (1996) Long-term results ofa prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.J Clin Oncol 14: 859–868Google Scholar
  187. Pisters PWT, Leung DHY,WoodruffJ, Shi WJ, Brennan MF (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14: 1679–1689Google Scholar
  188. Pollock RE, Karnell LH, Menck HR, Winchester DP (1996) The National Can- cer Data Base Report an soft tissue sarcoma.Cancer 78: 2247–2257Google Scholar
  189. Prendiville J, Murphy D, Renninson J, Buckley H, Crowther D (1994) Carcinosarcoma of the ovary treated over a 10-year period at the ChristieHospital. Int J Gynecol Cancer 4: 200–205PubMedGoogle Scholar
  190. Prevel CD, Hanel DP (1996) Fibro-osseous pseudotumor of the distal phalanx.Ann Plastic Surg 36: 321–324Google Scholar
  191. Prott FJ, Potter R, Micke O, Brunke MC, Haverkamp U, Wagner W, Willich N (1995) Ergebnisse der Bestrahlung von Weichteilsarkomen mit schnellen Neutronen.Tumor Diagn Ther 16: 194–199Google Scholar
  192. Putnam JB, Roth JA (1995) Surgical tareatment for pulmonary metastases from sarcoma. Hematol Oncol Clin N Am 9: 869–887Google Scholar
  193. Quezado MM, Middleton LP, Bryant B, Lane K, Weiss SW, Merino MJ (1998) Allelic loss an chromosome 22q in epitheloid sarcomas. Hum Pathol 29: 604–608PubMedGoogle Scholar
  194. Raaf HN, Raaf JH (1994) Sarcomas related to the heart and vasculature. Semin Surg Oncol 10: 374–382PubMedGoogle Scholar
  195. Ratto GB,Toma S, Civalleri D et al. (1996) Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 112: 614–622Google Scholar
  196. Recchia F, Ginaldi L, Discepoli S, Demartinis M, Coloni F, Quaglino D (1996) Autologous bone marrow transplantation for uterine sarcoma. Case report. Eur J Cancer 32A: 553–554Google Scholar
  197. Reichmuth C, Markus MA, Hillemanns M, Atkinson MJ, Unni KK, Saretzki G, Hofler H (1996) The diagnostic potential of the chromosome translocation T(2–13) rhabdomyosarcoma–a Pcr study of fresh-frozen and parafin-embedded tumour samples.J Pathol 180: 50–57Google Scholar
  198. Resnik E,Chambers SK,Carcangiu ML, Kohom EI, Schwartz PE,Chambers JT (1996) Malignant uterine smooth muscle tumors - role of etoposide, cisplatin, and dosorubicin ( EPA) chemotherapy. J Surg Oncol 63: 145–147Google Scholar
  199. Ricotti E, Fagioli F,Garelli E,Linari C,Crescenzio N,Horenstine AL et aí.(1998) c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood 91: 2397–2405Google Scholar
  200. Rodenberg J, Jensen OM, Keller J, Nielson OS, Bunger C,Jurik AG (1996) Fibrous dysplasia of the spine,costae and hemipelvis with sarcomatous trabsformation. Skeletal Radiol 25: 682–684Google Scholar
  201. Rosenbaum T, Kim HA, Boissy YL, Ling B, Ratner N (1999) Neurofibromin,the neurofibromatosis type 1 Ras-GAP, is required for appropriate PO expression and myelination. Ann N Y Acad Sci 883:-203–214Google Scholar
  202. Rossi CR, Foletto M, Alessio S, Menin N, Damore E, Rigon A, Lise M (1996) Limb-sparing treatment for soft tissue sarcomas–influence of prognostic factors. J Surg Onco163: 3–8Google Scholar
  203. Rossi CR, Foletto M, Vecchiato A et a1. 1996 ) TNF-alpha and doxorubicin in hyperthermic perfusion for Limb sarcomas–phase I-II study. Oncol Rep 3: 1059–1061PubMedGoogle Scholar
  204. Rusch VW (1995) Pulmonary metastasectomy–current indications. Chest 107 [Suppl S]: 322–331Google Scholar
  205. Santoro A,TurszT,Mouridsen H et al. (1995) Doxorubicin versus cyvadic versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas–a randomized study ofThe European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.J Clin Oncol 13: 1537–1545Google Scholar
  206. Sauer H, Hagena FW (1994) Osteosarkome. ln:Wilmanns W, Huhn D, Wilms K ( Hrsg) Internistische Onkologie.Thieme, Stuttgart, S 622–632Google Scholar
  207. Sauer H, Jauch KW (1994) Weichteilsarkome. In: Wilmannns W, Huhn D, Wilms K (Hrsg) Internistische Onkologie.Thieme, Stuttgart, S 640–652Google Scholar
  208. Sauer H (1995) Adjuvante Chemotherapie bei Weichteilsarkomen? Strahlenther Onkol 171: 185–194PubMedGoogle Scholar
  209. Sauer H (1995) Primäre operativeTherapie von Lungenmetastasen bei Weichgewebssarkomen. Pro und Contra aus der Sicht des Onkologen. Onkologe 1: 133–135Google Scholar
  210. Scheffzek K,Ahmadian MR,Wiesmuller L, Kabsch W, Stege P, Schmitz F,Wittinghofer A (1998) Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J 17: 4313–4327Google Scholar
  211. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467–470PubMedGoogle Scholar
  212. Schipper DL, Wagener DJT (1996) Chemotherapy of gastric cancer (review). Anticancer Drugs 7: 137–149PubMedGoogle Scholar
  213. Schlag PM, Kettelhack C (1995) Isolated, D., limb perfusion with tumor necrosis factor and melphalan–a new method in the treatment of regional melanoma metastases and locally advanced soft-tissue sarcoma (review).Onkologie 18: 123–125Google Scholar
  214. Schmitz N, Gratwohl A, Goldmann JM (1996) Allogenic and autologous transplantation for haematologic diseases, solid tumors and immune disorders.Current practice in Europe in 1906 and proposal of an operational classification. Bone Marr Transplant 17: 471–477Google Scholar
  215. Schütte J (1995) Chemotherapie der Weichgewebssarkome. Onkologe 1: 119–125Google Scholar
  216. Schwarzbach M, Lehnert T, Willeke F, Hinz U, Herfarth C (1996) Ergebnisse der isolierten hyperthermen Extremitätenperfusion bei Weichteilsarkomen im Rahmen eines multimodalen Behandlungskonzeptes. Chirurg 67: 1237–1243PubMedGoogle Scholar
  217. Schwarzbach M,Willeke F,Eble M,LehnertT,EwerbeckV,Wannenmacher M, Herfarth C (1996) Intraoperative Radiotherapie bei fortgeschrittenen Weichgewebssarkomen der Extremitäten. Langenbecks Arch Surg 113 [Suppl 21: 214–217Google Scholar
  218. Schwickerath J, Kunzig HJ (1995) Die spontane maligne Transformation einer extraabdominalen Fibromatose in ein Fibrosarkom. Geburtsh Frauenheilk 55: 173–175PubMedGoogle Scholar
  219. Scully SP,Oleson JR, Leopold KA,Samulski TV, Dodge R, Harrelson JM (1994) Clinical outcome after neoadjuvant thermoradiotherapy in high-grade soft tissue sarcomas.J Surg Onco157:143–151Google Scholar
  220. Sharpe JC, Ahern RP, Fischer C, Blake P, Shepherd J, Gore ME (1995) Carcinosarcoma of the ovary–Incidence, prognosis, treatment and survival of patients. Ann Onco16: 755–758Google Scholar
  221. Sieb JP, Mattle H, Pirovino M (1989) Neurofibrosarkome bei Neurofibromatose 1. Übersicht. Dtsch Med Wschr 114: 431–434PubMedGoogle Scholar
  222. Siebenrock KA, Nascimento AG, Rock MG (1996) Comparison of soft tissue Ewing’s sarcoma and peripheral neuroectodermal tumor.Clin Orthop Rel Res 326: 288–299Google Scholar
  223. Simsir A,Osborne BM,Greenebaum E (1996) Malignant granular cell tumor - a case report and review of the recent literature. Hum Pathol 27: 853858Google Scholar
  224. Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ (1995) Prognostic factors predictive of survival for truncal and retroperitoneal soft tissue sarcoma. Ann Surg 221: 185–195PubMedGoogle Scholar
  225. Skubitz KM, Hamdan H,Thompson RC (1993) Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas. Cancer 72: 2963–2969Google Scholar
  226. Smith R, Athanasou NA, Vipond SE (1996) Fibrodysplasia (myositis) ossificans progressiva–clinicopathological features and natural history. QJM 89: 445–456PubMedGoogle Scholar
  227. Solbiati L, IeraceT,Goldberg SN et al. (1997) Percutaneous USguided radio-frequency tissue ablation of liver metastases–treatment and followup in 16 patients. Radio) 202: 195–203Google Scholar
  228. Soler R,CastroJM, Rodriguez E (1996) Value of MR findings in predicting the nature of the soft tissue lesions–benign, malignant or undetermined lesion.Comput Med Imaging Graph 20: 163–169Google Scholar
  229. Sorensen S, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and Malignant Neoplasms. N Engl J Med 314: 1010–1014Google Scholar
  230. Spiro IJ, Rosenberg AE,Springfield D,Suit H,Phil D (1995) Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity-The Massachusetts General Hospital Experience.Cancer Invest 13: 86–95Google Scholar
  231. Spitzer G, Dunphy FR, Bowers CE,Adkins DR (1994) High-dose therapy with stem cell support in solid tumors. Med OncolTumor Pharmacother 11: 53–61Google Scholar
  232. Staren ED, Lynch G, Boyle C, WittTR, Bines SD (1994) Malignant cystosarcoma phyllodes.Am Surg 60: 583–585Google Scholar
  233. Stein U, Shoemaker RH, Schlag PM (1996) MDR1 gene expression -evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas. Eur J Cancer 32A: 86–92Google Scholar
  234. Steinau HU, Hebebrand D,Vogt P,Josten C (1996) Soft-tissue reconstruction in segmental defects of the lower leg.Chirurg 67: 1080–1086Google Scholar
  235. Steinau HU, Hebebrand D, Vogt PM, Hussmann J (1995) Weichgewebssarkome, Rehabilitation and Sekundäreingriff.Onkologe 1: 126–131Google Scholar
  236. Suit H, Spiro 1, Mankin HJ, Efird J, Rosenberg AE (1996) Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol 14: 2365–2369PubMedGoogle Scholar
  237. Suit H,Spiro 1(1995) Radiation as a therapeutic modality in sarcomas of the soft tissue. Hematol Oncol Clin N Am 9:733–746Google Scholar
  238. Suit H (1995) Sarcoma of soft tissues–radiation sensitivity,treatment field margins, pathological margins, and dose. Int J Radiat Oncol Biol Phys 32: 1545–1546PubMedGoogle Scholar
  239. Sutton G, Blessing JA, Park R, Disaia PJ, Rosenshein N (1996) Ifosfamide treatment of recurrent metastastatic endometrial stromal sarcomas previously unexposed to chemotherapy- a study of the gynecologic oncology group. Obstet Gynecol87: 747–750Google Scholar
  240. Taubert H, Meye A,Wurl P (1996) Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients. Cancer Res 56: 4134–4136PubMedGoogle Scholar
  241. Tejpar S, Nollet F, Li C et al. 1999 ) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).Oncogene 18: 6615–6620PubMedGoogle Scholar
  242. Tierney JF, Mosseri V,Stewart LA, Souhami RL, Parmar MKB (1995) Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer 72: 469–475Google Scholar
  243. Toguchida J,YamaguchiT, Dayton SH et al. (1992) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326: 1301–1308Google Scholar
  244. Trovik CS, Bauer HCF (1994) Local recurrence of soft tissue sarcoma: a risk factor for Tate metastases–379 patients of followed for 0.5–20 years. Acta Orthop Scand 65: 553–558PubMedGoogle Scholar
  245. Tunn PU, Schlag PM (1996) Diagnosis and treatment of malignant soft-tissue tumours (review). Dtsch Med Wschr 121: 175–178PubMedGoogle Scholar
  246. Tunn PU, Schlag PM (1995) Früherkennung von Weichgewebs- and Extremitätentumoren.Onkologie 18 [Supp13161–63Google Scholar
  247. TurszT (1996) High-dose ifosfamide in the treatment of advanced soft tissue sarcomas. Semin Oncol 23 [Suppl 7]: 34–39Google Scholar
  248. Valle AA, Kraybill WG (1996) Management of soft tissue sarcomas of the extremity in adults.J Surg Onco163:271–279Google Scholar
  249. Van Oosterom AT, Verweij J (1995) New drugs for the treatment of sarcomas. Hematol Oncol Clin N Am 9: 909–925Google Scholar
  250. Van Oosterom AT, Judson I, Verweij J et al. (2001) Safety and efficacy (STI571) in metastatic gastrointestinal stromal tumors: a phase I Study. Lancet 358: 1421–1423PubMedGoogle Scholar
  251. Van Ooosterom AT, Judson IR,Verweij et al. (2002) Update of phase I study of imatinib (ST1571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cncer 38 [Suppl 51: 583–87Google Scholar
  252. Van den Abbeele AD, Badawi RD (2002) Use of positron emission tomography in oncology and its potential role to assess response to imatinib therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 38 [Suppl 5]: S60–65PubMedGoogle Scholar
  253. Vandenberghe H (1996)The marriage of pathologyand genetics in soft tissue tumours - EACR-Muhlbock Memorial Lecture. Eur J Cancer 32A: 1849–1856Google Scholar
  254. Vangeel AN, Pastorino U, Jauch KW et al. (1996) Surgical treatment of lung metastases -The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Study of 255 Patients. Cancer 77: 675–682Google Scholar
  255. Vanginkel R,.,Koops HS, Devries EGE, Molenaar WM, Uges DRA, Hoekstra HJ (1996) Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone. Eur J Surg Oncol 22: 528–531Google Scholar
  256. Vanrijswijk REN,Tognon G, Burger CW, Baak JP, Kenemans P,Vermorken JB (1994) The effect of chemotherapy an the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract. Int J Gynecol Cancer 4: 52–60Google Scholar
  257. Vanunnik JAM (1995) Classification and grading of soft tissue sarcomas. Hematol Oncol Clin N Am 9: 677–700Google Scholar
  258. Verweij J, van Oosterom AT, Somers R et al. (1992) Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. Ann Onco13 [Supp12]: 75–80Google Scholar
  259. Verweij J, Catimel G, Sulkes A, Sternberg C, Wolff I, Aamdal S, Vanhoesel Q (1995 a) Phase II studies of docetaxel in the treatment of various solid tumours. Eur J Cancer 31A [Supp14]:21–24Google Scholar
  260. Verweij J, Mouridsen HT, Nielssen OS et al. (1995 b) The present state of the art in chemotherapy for soft tissue sarcomas in adults - the EORTC point of view (review). Crit Rev Oncol Hematol20:193–201Google Scholar
  261. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF (1999) Mouse tumor model for neurofibromatosis type 1.Science 286: 2176–2179Google Scholar
  262. Vogl TJ, von Wickede M, Hochmuth K et al. (1995) Bildgebende Diagnostik von Weichteilsarkomen.Onkologe 1: 93–100Google Scholar
  263. Wagner G, Hermanek P (1995) Organspezifische Tumordokumentation. Maligne Weichteiltumoren. Springer, Berlin Heidelberg New York Tokyo, S 27.1–27. 30Google Scholar
  264. Wang X, Mori 1, Tang W et al. (2002) Gastrointestinal stromal tumors: Are they of cajal cell origin? Exp Mol Pthol 72: 172–177Google Scholar
  265. Ward WG, Sekiya JK, Pope TE (1996) Traumatic ossifying periostitis of the ulna masquerading as a malignancy in a football player- a case report and literature review. Am J Sports Med 24: 852–856PubMedGoogle Scholar
  266. Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast.3.Carcinosarcoma. Cancer 64: 1490–1499PubMedGoogle Scholar
  267. Weh Hi, de Wit M, Zornig C, Hossfeld KD (1996) Doxorubicin/Ifosfamid 4G-CSF in der Behandlung metastasierter Weichteilsarkome: Eine hämatotoxischeTherapie.Onkologie 19: 159–162Google Scholar
  268. Weiss S (1994) Histological typing of soft tissue tumours, 2nd edn. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  269. Wendtner CM,Abdel-Rahman S, Krych M et al. (2002) Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts longterm survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.J Clin Onco120:3156–3164Google Scholar
  270. Wiedemann GJ, Robins HI, Gutsche Set al. (1996 a) Ifosfamide, carboplatin and etoposice (ICE) combined with 41.8-degrees-c whole body hyperthermia in patients with refractory sarcoma. Eur J Cancer 32A: 888892Google Scholar
  271. Wiedemann GJ, Robins HI, Katschinski DM et al. ( 1996 b) Klinische Studien zur Kombination von Ifosfamid, Carboplatin und Etoposid ( ICE) mit Ganzkörperhyperthermie. Med Klin 91: 279–283Google Scholar
  272. WiklundT, Huuhtanen R, Blomqvist C et al.(1996)The importance ofa multidisciplinary group in the treatment of soft tissue sarcomas. Eur J Cancer 32A: 269–273Google Scholar
  273. Willeke F, Eble MJ, Lehnert T, Schwarzbach M, Hinz U, Wannenmacher M, Herfarth C (1995) Die intraoperative Strahlentherapie im Behandlungskonzept retroperitonealer Weichgewebesarkome. Chirurg 66: 899–904PubMedGoogle Scholar
  274. Wirbel Ri, Schulte M, Mutschler W (1996) Primär maligne Knochen- und Weichteiltumore des Beckens–Onkologische und funktionelle Ergebnisse. Langenbecks Arch Surg 115: [Suppl 21: 914–917Google Scholar
  275. Wolf RE, Enneking WF (1996) The staging and surgery of musculoskeletal neoplasms.Orthop Clin N Am 27: 473 ffGoogle Scholar
  276. Wunder JS, Bull SB,AneliunasV et al. (2000) MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 18: 2685–2694PubMedGoogle Scholar
  277. Wunder JS, Czitrom AA, Kandel R, Andrulis IL (1991) Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.J Natl Cancer Inst 83: 194–200Google Scholar
  278. Wurl P,Meye A, Lautenschlager C et al. (1999) Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas. Cancer Lett 139: 159–165Google Scholar
  279. Wust P, Hildebrandt B,Sreenivasa G et al. (2001) Hyperthermia in combined treatment of cancer. Lancet Onco13: 487–497Google Scholar
  280. Young RH (1987) Carcinosarcoma of the urinary bladder. Cancer 59: 1333–1339PubMedGoogle Scholar
  281. Zagars GK, Mullen JR, Pollack A (1996) Malignant fibrous histiocytoma–outcome and prognostic factors following conservation surgery and radiotherapy.lnt J Radiat Oncol Biol Phys 15: 983–994Google Scholar
  282. Zahm SH, Fruameni JF Jr (1997) The epidemiology of soft tissue sarcoma. Semin Oncol 24: 504–514PubMedGoogle Scholar
  283. Zalupski MM, Baker LH (1995) Systemic adjuvant chemotherapy for soft tissue sarcomas. Hematol Oncol Clin N Am 9: 787–800Google Scholar
  284. Zerkowski HR, Hofmann HS, Gybels 1, Knolle J (1996) Primary sarcoma of pulmonary artery and valve–multimodality treatment by chemotherapy and homograft replacement. J Thorac Cardiovasc Surg 112: 1122–1124PubMedGoogle Scholar
  285. Zhang L,Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE (2000) Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synvial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res 60: 3655–3661Google Scholar
  286. Zoller ME, Rembeck B4Oden A,Samuelsson M,Angervall L (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79: 2125–2131Google Scholar
  287. Zomig C, Peiper M, Schroder S (1995) Re-excision of soft tissue sarcoma after inadequate initial operation. Brit J Surg 82: 278–279Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • H. Sauer
  • C. Wendtner
  • M. Schlemmer
  • R. D. Issels
  • W. Hiddemann

There are no affiliations available

Personalised recommendations